By a News Reporter-Staff News Editor at Obesity, Fitness& Wellness Week Castle Creek Pharmaceuticals, LLC, a global company dedicated to delivering transformative therapies to patients with dermatologic and head/neck orphan diseases and underserved conditions, announced completion of an exclusive license agreement for all U.S. rights to Arlevert
LOS ANGELES Wednesday AHF lauded the publication of clinical trial results in the journal Lancet which showed 100 percent efficacy in preventing Ebola virus infection among study participants who received an experimental vaccine in Sierra Leone and Guinea. Every year the world collectively spends almost $2 trillion on defense and only $36 billio
The FDA issued an earlier set of recommendations in October 2014, which recommended ways for manufacturers to build cybersecurity protections into medical devices as they`re being designed and developed. The FDA recommends manufacturers continually monitor cybersecurity vulnerabilities of devices and should create a program to mitigate these risks.
Dec. 31 The Affordable Care Act President Barack Obama's landmark health reform bill took some hits in 2016, but it could be in for a real beatdown this year. It's unclear what will become of the Affordable Care Act under a Donald Trump presidency. "It was a difficult year because of the departures by insurers," said Paul Ginsburg, director
-Zion Research has published a new report Titled Blood Pressure Monitoring Device Market by Device Type and by Accessory Type for Hospitals, Homecare, Diagnostics Laboratory and Others Global Industry Perspective, Comprehensive Analysis and Forecast, 2015 2021. According to the report, the globalblood pressure monitoring device marketaccounted for.
By a News Reporter-Staff News Editor at Investment Weekly News Research and Markets has announced the addition of the "Outpatient Care Centers Global Market Briefing 2017" report to their offering. The Outpatient Care Centers Global Market Briefing provides strategists, marketers and senior management with the critical information they need to as
Sri Lanka`s Minister of Health Dr. Rajitha Senaratne has decided to reduce the prices of surgical equipment, coinciding with the move to slash the prices of essential medicinal drugs. Minister Rajitha Senaratne has given instructions to the National Drugs Regulatory Authority to draft a proper mechanism to reduce the prices of surgical equipment.
Humacyte, an innovator in biotechnology and regenerative medicine, announced today the initiation of a U.S. Phase II arterial bypass clinical trial of HUMACYL, its investigational human acellular vessel, to test the safety and efficacy as a lower extremity arterial bypass vessel in patients with peripheral arterial disease. The initiation of the Ph
Pharmaceutical company Lupin has received tentative approval from the United States Food and Drug Administration to market its cholesterol lowering Pitavastatin tablets in the American market. has received approval for Pitavastatin tablets in the strength of 1 milligram, 2 mg and 4 mg. Pitavastatin is a generic version of Kowa's Livalo tablets in t
The medical power supply devices market is estimated to be valued at US$ 1,263.3 Mn by the end of 2016 and is anticipated to expand at a CAGR of 4.5% from 2016 to 2022, to account for US$ 1,613.9 Mn by 2022.. Power supply devices, also known as electric power converters, are electronic devices that convert one form of electrical energy into another
Its three diagnostic imaging centers in the Naples area will be acquired by the NCH Healthcare System, effective Jan. 1. All of the centers will remain open and will be combined with NCH's existing outpatient radiology offices to create NCH Imaging, said Debbie Curry, a spokeswoman for NCH, in an email. NDIC has operated as an NCH affiliate, with r
By a News Reporter-Staff News Editor at Marketing Weekly News The biopharmaceutical company Dompe announced the acceptance of the registration application submitted to the European Medicines Agency for Oxervate eye drops, for the treatment of moderate and severe neurotrophic keratitis in adult patients. Acceptance by EMA constitutes the...
HONOLULU Eager to stop Republicans from destroying his signature health care law, President Barack Obama and Democratic lawmakers will meet next week to try to forge a common strategy. The White House is casting it as an effort to unite Democrats behind a plan to protect the law, known as the Affordable Care Act, before Republicans have a chance to
In 2016, many new and useful medications got FDA approval. My articles are syndicated worldwide, but I'm only listing English drug names so please ask your local pharmacist to translate the medication name for your country. So the FDA approved this injectable drug to help people who have been exposed from infected animals, contaimated animal produc
Heavy Metal and makeup have more in common than you might know. Lipsticks, mascara, sunblock, and deodorant are just a few of the toxic products that contain levels of heavy metals and other substances that are unregulated by the FDA. Unlike drug companies, cosmetics companies may use almost any ingredients they choose, with few exceptions.
By a News Reporter-Staff News Editor at Politics& Government Week A patent application by the inventors Chatterjee, Samir; Lee, Edward Kuang-Yu; Alluhaidan, Ala; Alnosayan, Nagla Sulaiman, filed on June 9, 2015, was made available online on December 17, 2015, according to news reporting originating from Washington, D.C., by VerticalNews correspon
Others ask how their name popped up on the Blue Cross call list. Blue Cross, the state's largest health insurer, is engaging in an experiment that may one day become standard practice in private health insurance, as the industry contends with rising costs. Using a computer algorithm to identify customers, Blue Cross is deploying teams of nurses and
Dec. 31 At the eleventh hour, BlueCross BlueShield of Arizona and Carondelet Health Network have signed a four-year contract, putting to rest fears that customers of the state's largest insurer could lose in-network access to Carondelet doctors and facilities. The agreement includes all Carondelet hospitals, employed physicians, ambulatory surger
By a News Reporter-Staff News Editor at Politics& Government Week Clovis Oncology, Inc. announced that the U.S. Food and Drug Administration has extended the Prescription Drug User Fee Act date for Clovis' New Drug Application for rociletinib by the standard extension period of three months with the new goal date of June 28, 2016. Clovis Oncology
Data on Neuroendocrine Cancer Reported by Researchers at S. Orsola-Malpighi University Hospital. According to news reporting from Bologna, Italy, by VerticalNews journalists, research stated, "This study was performed to investigate the role of Ga-68-DOTANOC SUVmax as a potential prognostic factor in patients with pancreatic neuroendocrine tumor.
This TforG report includes the Surgical Procedures Database with 620 surgical interventions, reported by the ICD-9 coding system in Argentina. Economic Outlook:- In spite of the forecasted acceleration in the global economy, for Argentina, the economic growth is expected to slow down in 2015 and make a slight recuperation to growth in 2016.- The
This TforG report includes the Surgical Procedures Database with 620 surgical interventions, reported by the ICD-9 coding system in UAE. To add context to the surgical procedure volumes, the report provides written and numerical analysis on the current trends, size, changes and dynamics of the local markets. -Abu Dhabi is especially dependent on
Release date- 28122015- Eisai Co., Ltd. announced today that regarding the acquisition of Chinese generic pharmaceutical company Liaoning TianYi Biological Pharmaceutical Co., Ltd. previously announced on November 27, 2015, the conditions of transfer have been arranged, including receiving a new business license from the regulatory authority in Chi
Dec. 31 Israeli placenta-based cell therapy developer Pluristem Therapeutics Ltd. has been awarded orphan drug status by the US Food and Drug Administration for its PLX-PAD cells treatment for severe preeclampsia. We are encouraged by the US FDA designation that demonstrates Pluristem's commitment to the program and the potential promise it holds
Bangor Hydro-Electric Co., et al., 81818 Federal Reserve System NOTICES Changes in Bank Control: Acquisitions of Shares of a Bank or Bank Holding Company, 81818-81819 Fiscal Service NOTICES Prompt Payment Interest Rate; Contract Disputes Act, 81880 Food and Drug Administration NOTICES Guidance: Emerging Postmarket Medical Device Signals, 81829-8183